Statement: patients who have been diagnosed with hormone receptor positive advanced breast cancer and have received chemotherapy for the same in the past are eligible to partake in the primary clinical trial
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).